Avicanna reported annual revenue of CA$25.5 million ($18.38 million) for the year ended December 31, 2024, up 52% compared to ...

Avicanna Inc. ("Avicanna" or the "Company) , a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to ...